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Abstract 
Background:  Extremely preterm (EP, <28 weeks’ gestation) individuals have increased risk 
of cognitive deficits compared with controls.  The posterior cingulate region has an important 
role in cognitive function, but how this is affected by preterm birth is unknown.  We aimed to 
compare brain metabolite ratios of neurons and cell membranes between EP 18-year-olds and 
controls, and explore the association between metabolite ratios and cognitive outcomes. 
Method:  A regional cohort of 150 EP and 134 controls.  Cerebral metabolites were measured 
using proton MRS obtained from a left posterior cingulate voxel.  Total N-
acetylaspartate(tNAA, neuronal marker)/total creatine(tCr) and total choline(tCho, cell 
membrane marker)/tCr ratios were compared between groups using linear regression.  
Metabolite ratios were correlated with tests of general intelligence (IQ), memory and 
attention using linear or logistic regression. 
Results:  Compared with controls, EP had lower tNAA/tCr (mean difference [95% CI] of -
2.27%[-4.09, -0.45]) and tCho/tCr (mean difference [95% CI] of -11.11%[-20.37, -1.85]), all 
p=0.02.  Higher tCho/tCr correlated with better IQ in the EP group only; whereas higher 
tNAA/tCr ratios correlated with better scores in working memory and attention in both 
groups. 
Conclusion:  EP birth is associated with long-term brain metabolite ratio alterations.  This 
may underlie poorer cognitive performance in EP survivors.   
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Introduction 
Although survival rates following extremely preterm (EP, <28 weeks’ gestation) birth have 
increased in the last few decades, significant neurodevelopmental sequelae affects around 25-
35% of survivors.(1)  These deficits encompass poorer general intelligence (IQ), academic 
underachievement, behavioral, attentional, socialization problems, and major motor 
deficits.(1-3) 
 
Magnetic resonance imaging (MRI) studies have contributed substantially to the 
understanding and characterization of preterm brain injury.  Brain alterations in preterm 
children noted on structural(4, 5) and diffusion tensor MRI(6) have been shown to correlate 
with cognitive, motor and behavioural outcomes in childhood and adolescence.(4, 5)  Brain 
metabolites measured using magnetic resonance spectroscopy (MRS) may provide insights 
into the structural changes observed in volumetric and diffusion MRI studies.  Using proton 
(1H) MRS, metabolites including N-acetylaspartate (NAA), choline-containing compounds 
(Cho), and creatine (Cr) can be quantified.  NAA is primarily found in neurons and is a 
marker of neuronal integrity.(7)  The Cho peak on MRS has a contribution from several 
choline-containing compounds.  High Cho levels are reported in pathologies involving 
increased cellular density and proliferation of membrane phospholipids.(8)  The Cr resonance 
comprises creatine and phosphocreatine, compounds involved in cellular energy 
metabolism.(9)  Cr levels remain relatively stable after the first year following birth(10) and 
are often used as a reference in MRS ratios.  Although MRS metabolites are presented either 
as ratios or absolute concentrations, it is not always feasible to obtain the latter in clinical 
studies due to time constraints related to the imaging protocol.  Most brain MRS studies in 
preterm populations have been performed during the neonatal period (34 weeks’ 
postmenstrual age up to term-equivalent age).(11-13)  There is limited information on MRS 
brain metabolites and associated functional outcomes in preterm young adults.(14, 15)  
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The posterior cingulate cortex is a highly connected brain region with diverse functions that 
encompass IQ, working memory, attention and executive function,(16) all of which are 
domains that are impaired in the preterm population.(3, 17, 18) Abnormalities of posterior 
cingulate brain structure, metabolic activity and function have been documented in 
neurodegenerative disorders, healthy ageing, major psychiatric disorders and traumatic brain 
injury.(16)  However, how posterior cingulate metabolites are affected following EP birth is 
not known.  
 
To address these research gaps, we aimed to understand the impact of EP birth on posterior 
cingulate brain metabolites in adolescence, and how the metabolites relate to function.  We 
aimed to (i) compare MRS metabolite ratios that reflect neuronal integrity and cell 
membranes i.e. total (t)NAA/tCr and tCho/tCr between EP and controls, and (ii) explore the 
relationship between MRS metabolite ratios and IQ, working memory and attention at age 18 
years and whether these relationships differ between EP and controls.  Given that we have 
previously reported an association between larger brain white matter volumes and higher 
IQ,(5) we also wanted to explore whether the associations between MRS metabolite ratios 
and cognitive outcomes were independent of white matter volume in this region.  We 
hypothesised that the EP group would have lower tNAA/tCR and tCho/tCr compared with 
term controls, and that higher tNAA/tCr within the posterior cingulate would predict better 
IQ, working memory and attention, independent of white matter volume. 
 
Results 
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For the 18-year follow up study, 172 (76% of those alive at 8 years of age) of the EP group 
and 160 (63%) of the term-control group were seen, of whom 150 EP and 134 controls had 
MRS data.  The mean Cramer-Rao low bounds (expressed as a percentage of the fitted 
metabolite amplitude) for the included spectra were: tCho 7.8 +/- 3.1%; tNaa 3.0 +/- 0.9%; 
tCr 4.0 +/- 1.0%. 
 
Compared with EP survivors in the original cohort, EP participants who contributed MRS 
data to this study had higher IQ at 8 years (mean difference [95% CI] of 7.0 [1.9, 12.1]), 
lower rates of cerebral palsy at 8 years (7.5 vs 25%) and less cystic periventricular 
leukomalacia (3.3 vs 14.7%).  Controls with MRS data had higher IQ at 8 years (mean 
difference [95% CI] of 6.2 [2.4, 10.1]), were more likely to be singletons (100 vs 95%), and 
were less likely to have mothers with fewer than 12 years of education (32.3 vs 46.4%) than 
controls without MRS data.  All other characteristics were similar. 
 
Participant characteristics of those included in the current study are summarized in Table 1.  
Expected differences between groups were seen in all characteristics with the exception of 
male sex and small for gestational age at birth. 
 
MRS metabolite peak-area ratios (Table 2) 
Compared with controls, EP adolescents had lower tNAA/tCr and tCho/tCr ratios.  The 
magnitude of reduction in tCho/tCr was almost five-fold that of tNAA/tCr. 
  
Relationship between MRS metabolite peak-area ratios and outcomes (Tables 3 & 4) 
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IQ, working memory and attention outcomes are summarized in Table 3.  Compared with 
term-born controls, the EP group had lower IQ and performed more poorly in most tasks of 
working memory and attention, with the exception of immediate auditory memory and 
selective visual attention. 
 
Metabolite ratios involving tCho were associated with IQ, whereas ratios involving tNAA 
were associated with working memory and shifting attention (Table 4).  Increased tCho/tCr 
ratios were associated with better IQ; a relationship seen in the EP group only but not 
controls (p value for interaction 0.04).  tNAA/tCr ratios correlated positively with tests of 
working memory and shifting attention; a relationship that was similar in both EP and control 
groups (p value >0.05 for all interactions).  All relationships between MRS metabolite ratios 
and IQ, memory and attention persisted even after adjustment for posterior cingulate white 
matter volume.  
 
Discussion 
This study demonstrated that brain metabolite ratios tNAA/tCr and tCho/tCr in the posterior 
cingulate were lower in EP survivors in late adolescence compared with controls.  These 
brain metabolite ratios were associated with IQ, working memory and attention, independent 
of white matter volume in a similar brain region.  Interestingly the relationship between 
tCho/tCr with IQ was seen in the EP group but not controls.  This requires more study but 
may suggest that Cho is an important biomarker for cognitive dysfunction in EP survivors.  
 
Unfortunately we report values from metabolite ratios rather than absolute quantitation.  
MRS was obtained as part of an extensive MRI protocol and time limitations precluded 
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longer MRS acquisition, which was necessary to obtain absolute metabolite quantitation.  
Therefore the lower tNAA/tCr ratio in the EP survivors could be due to decreased NAA, 
increased Cr or both.  NAA is found predominantly in neurons, where concentrations 
increase in the early stages of gray matter, thalamic and cerebellar development.  This is 
thought to reflect the rapid formation of dendritic arborisations and synaptic connections.(10)  
In addition, NAA has a role in oligodendrocyte myelin formation, neuroimmune reactions 
and intercellular signalling.(19) NAA rapidly increases in the first few years following birth, 
then slows down to reach adult levels by mid-adolescence.(10, 20) Decreased NAA levels are 
seen in neurodegenerative disorders, such as Alzheimer’s disease and mild cognitive 
impairment,(21) cerebral atrophy in demyelinating and gray matter disorders,(22) as well as 
disorders characterized by a lack of progressive cortical development, such as early onset 
schizophrenia.(23)  The impact of preterm birth on NAA levels in adolescence is 
inconclusive.  One study reported lower NAA levels in the hippocampus of preterm 15-year 
olds compared with controls(14) but another reported similar NAA/Cr ratios in frontal white 
matter.(15)  Lower NAA levels in EP compared with controls in this study may reflect 
impairment in the early developmental formation of dendritic arborisations and synaptic 
connections, which persist into adolescence.(10, 23)   
 
Developmentally, Cho concentrations in the brain decrease in the first year after birth and 
remain relatively constant until early adulthood.(10)  Lower tCho/tCr ratios in the EP group 
could be a result of decreased Cho, increased Cr, or both.  The lower tCho/tCr ratios in the 
EP group suggest decreased membrane phospholipid content in the posterior cingulate.  This 
may be a result of disrupted Cho metabolism of membrane phospholipids following preterm 
birth, reflecting altered phospholipid turnover and development with potentially reduced 
content of dendrites and synapses, as well as cholinergic neurons.(24)  Our findings do not 
concur with a previous report where Cho/Cr ratios in the frontal white matter were similar 
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between preterm and control adolescents.(15)  However, in that study, the sample size was 
small (18 term controls and 18 very low birth weight adolescents) and the MRS was obtained 
from a different region of the brain.  There is no current data on MRS changes in the 
posterior cingulate region following EP birth. In the current study, we regarded Cr as a 
reference for NAA and Cho.  Cr levels remain relatively stable after the first year following 
birth,(10) however, caution is needed as Cr levels can change acutely in pathological 
conditions in experimental models.(25) 
 
The relationship between brain metabolite ratios in infancy and later developmental outcomes 
in preterm infants has been reported in early childhood, with little information in late 
adolescence. NAA/Cho ratios in the cerebellum positively correlated with cognitive scores on 
the Bayley-III developmental assessment at 2 years,(13) whereas higher NAA/Cho but lower 
Cho/Cr ratios in the posterior periventricular white matter were associated with better motor 
development at 1 year.(11)  Another study, however, did not find an association between 
NAA/Cho ratios in the deep nuclear gray matter and general development at 18 months to 2 
years.(26)  In the current study, higher tCho/tCr ratios in adolescence were associated with 
better IQ scores, whereas higher tNAA/tCr ratios were associated with better working 
memory and attention scores in adolescence.  The tCho/tCr-function relationships in 
adolescence are not reflective of the associations described by others in infancy.  This may be 
a result of different underlying processes affecting brain metabolite-function many years after 
preterm birth. 
 
There are, however, data from other adult-onset conditions that support the association 
between brain NAA and Cho and cognitive function.  Higher NAA/Cr and lower Cho/Cr are 
associated with cognitive functioning in Alzheimer’s disease, mild cognitive impairment, 
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schizophrenia and traumatic brain injury.(21, 27)  In Alzheimer’s disease and mild cognitive 
impairment, NAA/Cr ratios in the posterior cingulate region decreased with cognitive and 
memory decline associated with disease progression.(21, 27)  This is in contrast with the 
normal ageing process where increases in NAA, possibly neuronal hypertrophy, and Cho, 
reflecting glial proliferation, have been documented.(28)  In our study, we found that the 
relationships between metabolites and IQ were mostly involving Cho, whereas those with 
working memory and attention were related to NAA.  Of interest was the differential 
relationship between Cho ratios and IQ for the EP and control groups.  This may suggest 
vulnerability of choline-containing compounds following EP birth, and may reflect either 
delayed development or early decline of Cho.  Further research into potential alterations of 
choline function in preterm survivors is needed, given the paucity of such studies in the 
current literature.  
 
We have previously reported in this same cohort that volumes of multiple brain tissues and 
structures were smaller in the EP group compared with controls.(5)  Of particular relevance 
to this study was white matter volume; which was in the order of 6.0% smaller (95% 
confidence interval of -8.8% to -3.2%) in the EP group compared with controls.  In the 
present study, brain metabolites sampled from a specified region of white matter (left 
posterior cingulate) had lower tNAA/tCr and tCho/tCr in EP compared with controls.  Thus, 
we can speculate that not only is EP birth associated with long term effects on brain volumes, 
it is also associated with lower concentrations of brain metabolites that are markers of 
neurons and cell membranes within the white matter.  In addition, the previous study also 
reported an association between larger brain white matter volumes and higher IQ scores.  An 
interesting finding from the current study involves the relationships between MRS metabolite 
ratios and cognitive outcomes (IQ, memory and attention) which are independent of posterior 
cingulate white matter volumes.  This may suggest that following EP birth, brain metabolite 
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ratios are influencing cognitive function via alternative pathways to brain volumes, and 
highlights the need for further research into understanding these pathways. 
 
This study is the largest neuroimaging cohort of EP and term-born controls in the era of 
modern intensive care to be prospectively followed up to late adolescence.  With a 
contemporaneous group of term-born controls, we were able to make direct group 
comparisons of our MRS data rather than relying on normative data, which may not 
accurately reflect what is seen in our population.  In addition, there were functional outcome 
data from validated neuropsychological tests that investigated functions associated with the 
posterior cingulate cortex.  Thus, we were able to further understand how these metabolites 
are related to cognitive functioning in EP adolescents.  The differential relationship between 
tCho/tCr and IQ between EP and term controls seen in our study is a novel finding. This 
opens up the possibility of further research into how Cho may be differentially affected 
following preterm birth. 
 
Although a high proportion of participants consented to have MRI and MRS examinations, 
outcomes were only available for 60-78% of those originally recruited.  EP participants who 
returned for assessment had higher IQ at age 8 years, lower rates of brain injury and were less 
likely to have cerebral palsy compared with EP participants who were not assessed.  
Similarly, control participants who were assessed had higher IQ at 8 years and additionally 
were more likely to have mothers with greater than 12 years’ of education, than controls who 
did not return for assessment.  Thus, the differences we have observed may have been greater 
if the whole cohort had been assessed.  Finally, we had cross sectional MRS data rather than 
longitudinal data, which limited our ability to understand the trajectory of brain metabolite 
differences between the birth groups from birth until adolescence. 
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We identified brain metabolite profiles that reflect altered development involving dendrites, 
synaptic formation and membranes in EP infants in late adolescence.  This may underlie the 
association of EP birth with poorer performance on cognitive tasks.  Of concern was little 
evidence of developmental ‘catch-up’ of brain metabolites in late adolescence.  It thus 
highlights the importance of understanding how EP birth potentially impacts on the normal 
ageing process as more EP survivors reach adulthood. 
 
Methods 
Participants 
Participants were part of a prospective longitudinal cohort study of all EP adolescents born in 
the state of Victoria, Australia between 1991 and 1992.  Term-born controls were 
contemporaneously recruited at birth, matched to the EP cohort on expected date of birth, 
mother’s country of birth (English-speaking versus other) and health insurance status (private 
or public).  Follow up at ages 2,(29) 5(30) and 8 years have been previously reported.(31)  At 
age 18 years, participants attended a comprehensive health and developmental assessment 
including MRI and MRS.  Written informed consent was obtained from all participants, 
including their parents if aged less than 18 years at the time of assessment.  Ethical approval 
for the original and follow up studies were obtained from the Human Research and Ethics 
committees of the four participating centres i.e. the Royal Women’s Hospital, Mercy Hospital 
for Women, Monash Medical Centre and Royal Children’s Hospital, Melbourne. 
The MRI volumetric data, IQ and the attention data have previously been reported on this 
cohort.(5, 32, 33)  In this manuscript, we report the MRS data and how that relates to IQ, 
working memory and attention.  
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MRS 
MRS was performed at two study sites, each using a Siemens 3T MAGNETOM Trio MRI 
system (Siemens Healthcare, Erlangen, Germany), a 12-channel receive-only head coil, and 
the same acquisition protocol.  Proton (1H) MRS was obtained from a 20x15x10 mm voxel 
centred on the left posterior cingulate white matter (Figure 1) using a Point Resolved 
Spectroscopy (PRESS) acquisition (repetition time=3000ms, echo time=135ms, 128 
averages).  Spectra were quantified using LCModel.(34)  LCModel fits to in vivo spectra 
using a linear combination of simulated basis spectra for individual metabolites.   The basis 
set used for this study included NAA, N-acetyl-aspartate-glutamate (NAAG), choline 
containing compounds (phosphocholine (PCh) and glycero-phosphocholine (GPC)) and 
creatine (Cr) and phosphocreatine (PCr).  Metabolites were defined as follows: total NAA 
(tNAA) = NAA+NAAG; total choline (tCho) = GPC+PCh; total creatine (tCr) = Cr+PCr.  
LCModel provides an estimate of the standard deviation (SD) (Cramer-Rao lower bound) of 
the fitted amplitude of each metabolite included in the basis set expressed as a percentage of 
the amplitude.  Metabolites with SD >50% are unreliably determined; major metabolites 
should have SD <20%.(35)  Each spectrum was manually checked and excluded if all of 
tNAA, tCho and tCr had SD >20% indicating a poor quality spectrum.  In principle, 
LCModel allows estimation of absolute concentrations by reference to a separate 
unsuppressed water acquisition.  However, at an echo time of 135ms, large corrections for 
both water and metabolite T2 relaxations are required.  For this study, there was insufficient 
time to directly estimate T2 relaxation and so only the metabolite ratios were calculated.    
 
Outcome measures 
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For the purposes of this study we focussed on tests of functions thought to be associated with 
the posterior cingulate region, which included IQ, working memory and attention.(16)  
Participants were assessed by trained examiners who were unaware of previous clinical 
history or group allocation. 
 
IQ 
IQ was estimated using a two-subtest version of the Wechsler Abbreviated Scale of 
Intelligence (WASI).(36)  The WASI IQ provides a standardized scale with a mean of 100 
and SD of 15. 
 
Working Memory  
The Digit Recall and Backward Digit Recall subtests of the Working Memory Test Battery 
for Children were administered.  In both subtests participants were presented with a sequence 
of digits of increasing span.  In Digit Recall the participants were required to recall the 
sequence of digits in the same order as they were presented, while in Backward Digit Recall 
participants were required to recall the digits in the reverse order.  The maximum span i.e. the 
longest recall sequence was recorded. 
 
Attention  
Three measures of attention, all derived from the Test of Everyday Attention,(37) were used.  
(i) Visual selective attention: The Telephone Search task involved identifying target stimuli 
(maximum=20) that were interspersed amongst distractor stimuli in a simulated 
telephone directory.  
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(ii) Auditory selective attention: The Elevator with Distraction task involved participants 
imagining that they were in an elevator in which the visual floor indicator was not 
working.  Participants were asked to calculate which floor they were located by counting 
a series of specific tones while ignoring the presence of a distractor tone.  Ten trials were 
administered and the variable of interest was the number of correct trials (range 0-10). 
(iii) Shifting attention: The Elevator with Reversal task required participants to count strings 
of medium pitched tones.  Interspersed with these medium pitched tones were both high 
(indicating that the subject must switch to counting up) and low tones (indicating that the 
subject must switch to counting down). Ten trials were administered and the variable of 
interest was the number of correct trials (range 0-10). 
  
Statistical analyses 
Data were analysed using STATA 13.0 (StataCorp, College Station, Texas).  Participant 
characteristics were compared (i) between EP and controls, as well as (ii) participants with 
and without analysable MRS within the EP and control groups, using t-tests and chi squared.  
Group differences in MRS metabolite ratios were explored using linear regression fitted using 
generalized estimating equations with robust (sandwich) estimation of standard errors to 
allow for multiple births within a family, using separate models for each brain metabolite 
ratio.  IQ, memory and attention variables were compared between groups using t-tests, or 
Wilcoxon rank sum tests for non-normal data.  Unlike IQ scores, which were age-appropriate, 
the working memory and attention results were presented as raw scores and thus, analyses 
were repeated adjusted for corrected age at assessment.  The relationships between brain 
metabolite ratios and functional outcomes (that were approximately normally distributed) 
were explored using linear regression, again fitted using generalized estimating equations 
with robust (sandwich) estimation of standard errors, with a separate model for each 
metabolite ratio-outcome combination.  For functional outcome variables that had a skewed 
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distribution, we used logistic regression with the outcomes dichotomized using the median 
for the particular variable as the cut-point.  To determine whether the relationship between 
the metabolite ratio and outcome was the same in the EP and control groups, we used an 
interaction effect.  To determine whether MRS metabolite ratios independently predicted IQ, 
memory and attention, we added left posterior cingulate white matter volume as an additional 
step to the regression. Left posterior cingulate white matter volume was automatically 
generated from the T1-weighted structural MRI scan using FreeSurfer software as previously 
described.(5) 
 
We acknowledge the multiple comparisons within this study and hence we interpret our 
findings by focusing on overall patterns and magnitude of differences, rather than on 
individual p-values. 
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Figure legends 
Figure 1 Representative proton spectra and voxel placement centred on the left 
posterior cingulate region. 
 
